Mature CD4 + helper T lymphocytes have been categorized into two major functional phenotypes, T.1 and T.2, which produce distinct arrays of lymphokines and which are thought to arise from a pluripotential precursor cell termed T.0. Clonal anergy can be induced in TH1 clones by stimulating via the T cell receptor (TCR) complex in the absence of a costimulator molecule; however, anergy has been difficult to demonstrate in T.2 clones. We show here that treatment of cloned T.0 lines with anergizing stimuli results in the selective loss of T.1 characteristics and retention of a T.2 phenotype. Treated cells exhibit a substantial reduction in interleukin 2 (IL-2) production and antigen-specific cytolytic activity, but retain comparable IL-4 and IL-5 production in response to restimulation via the TCK complex. T.0 clones exposed to anergizing stimuli also increase in size, thus morphologically resembling T.2 cells. The signaling characteristics of these cells also are altered, in that they exhibit an devated basal level of intracellular free calcium which fails to increase significantly with subsequent restimulation, reminiscent of the signaling characteristics of T.2 cells. "Anergized" T.0 clones thus share several functional, morphologic, and physiologic properties with cells of the T.2 phenotype, suggesting that T.2 cells may arise when T.0 cells are stimulated via the TCR complex in the absence of a putative costimulator molecule.
H
elper T lymphocytes (HTL) 1 perform most of their effector functions via the activity of secreted lymphokines. Cloned CD4 + HTL lines can be segregated into at least two mature subsets, termed T.1 and T.2, on the basis of the array of secreted lymphokines. T.1 cells uniquely produce IL-2, lymphotoxin, and IFN-3,, whereas T.2 cells uniquely produce IL-4, IL-5, IL-6, and IL-10. Cells of both types can produce IL-3, TNF-cz, and GM-CSF (1, 2) . This distinction based on secreted lymphokines corresponds to functional phenotype. T.1 cells appear to be responsible for delayed type hypersensitivity reactions and activation of CD8 + cytolytic T lymphocytes, whereas T.2 cells are optimal at providing help for B cell proliferation and Ab production, particularly of the IgE and IgG1 isotypes (3, 4) . The T.1 and T.2 subsets, therefore, might mediate what have been traditionally referred to as the cellular and humoral classes of immune response, respectively.
Several lines of evidence have suggested that the mature T.I and T.2 cell phenotypes are not present among the population of naive peripheral CD4 + lymphocytes, but, rather, differentiate from that population after a primary activation event. Murine CD4 + splenocytes produce predominantly IL-2 but little or no IL-4 or IFN-3' when initially stimulated via the TCR complex (5, 6) . However, upon subsequent restimulation, that population secretes lymphokines characteristic of both the TH1 and T.2 subsets (5-7). When doned lines are derived from a bulk population of antigenprimed lymphocytes, three predominant types of cell are obtained: T.1 cells, T.2 cells, and a third type, designated T~0, which continues to produce lymphokines characteristic of both mature subsets (5, 8) . The relative proportion of each cell type obtained depends on the exogenous lymphokines present during the activation event or cloning procedure, and probably depends on the type of APC present as well (5, (9) (10) (11) . Many T~0 clones, when maintained in culture for several weeks, eventually simplify their lymphokine profile and acquire a more typical T.1 or T.2 phenotype (5, 8) . Collectively, these observations have suggested a model in which a resting CD4 + T cell, upon primary stimulation with specific antigen, differentiates into a pluripotential T~0 cell. This cell, under the influence of additional factors such as exogenous lymphokines and costimulatory molecules expressed by APCs, differentiates into a mature T.1 or T.2 effector cell (12) . However, the specific events governing this differentiation process on a clonal level remain undefined.
We have shown previously that TH1 and T.2 clones differ with respect to their TCK-associated signal transduction events. The generation of substantial levels of inositol phosphates and the elevation of intracellular free calcium ([Ca2+] i) that are readily detected after stimulation of T.1 cells via the TCR complex are not observed in T.2 cells (13) . Preliminary results have revealed that this difference may be secondary to differential expression of a particular isoform of phospholipase C (PLC), PLC~I (Goldfien, R., J. Imboden, T. Gajewski, and D. Qian, unpublished observations). In addition, lymphokine production by T.1 cells is substantially more sensitive to elevations in intracellular cAMP than is lymphokine production by T.2 cells (13) . The distinct signal transduction characteristics of T.I and T.2 clones probably relate to the unique function of each of the subsets.
Stimulation of T.1 cells via the TCR complex in the absence of an APC-derived costimulator molecule results, paradoxically, not in activation, but rather in an unresponsive state termed donal anergy (14) (15) (16) . This process is analogous to the generation of peripheral tolerance of T lymphocytes that have escaped thymic clonal deletion in vivo (17) , and is characterized by an inability to secrete IL-2 upon subsequent restimulation. Interestingly, anergy with respect to IL-4 production by T.2 clones cannot be similarly induced (18) , nor is the proliferation of those cells inhibited by anergizing stimuli (19, 20) , perhaps as a consequence of their distinct signaling mechanisms. In this study, we have examined the effect of anergizing stimuli on the functional properties and signaling characteristics of T.0 HTL clones. After induction of anergy, IL-2 production and antigen-specific cytolytic activity of these cells are specifically inhibited, but the ability to secrete IL-4 and IL-5 is preserved, consistent with a functional transition to a T,2-1ike cell. Moreover, these cells increase in size, exhibit increased basal levels of [Ca 2 + ]i, display minimal further increases in [Ca2+]1 after subsequent restimulation, consistent with a transition to a T.2-1ike signaling phenotype. Our observations support a model in which T.2 cells might arise when a T.0 intermediate is stimulated via the TCR complex in the absence ofa costimulator signal. They also predict that attempts to induce anergy by similar methods in vivo may actually generate a T.2-driven immune response rather than peripheral tolerance.
Materials and Methods
Animalt Female DBA/2, BALB/c, and CBA/J mice were purchased from Tbe Jackson Laboratory (Bar Harbor, ME). Mice were housed in a barrier facility and used between 6 and 12 wk of age.
Culture Media and Reagents. T cells were grown in culture medium consisting of DMEM plus 5% beat-inactivated FCS, 10 raM 3(N-morpholino)propane sulLfonic acid, 5 x 10 -s M 2-ME, 100 U/m] penicillin plus 100/~g/ml streptomycin, and additional amino acids (21) . The CTLI.-2 line used for lymphokine assays and the B lymphoma line LK35.2 were grown in the same complete medium containing 10% FCS. OVA, conalbumin, digitonin, Con A, and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) were purchased from Sigma Chemical Co. (St. Louis, MO). Ionomycin and Indo-1 acetoxymethylester were purchased from Calbiochem-Novabiochem/Corp. (San Diego, CA).
RecombinantLyraphokinesandrnA~ Recombinant routine IL-2 and mutine IL-4 were kindly provided by the DNAX Research Institute of Molecular and Cellular Biology (Palo Alto, CA). Recombinant human IL-2 was generously provided by Cetus Corp. (Emeryvilh, CA). Human rlL-2 was used for derivation and maintenance of T cell clones; murine rlL-2 was used as a standard in the Ib2 bioassay. All concentrations are expressed in units per milliliter as defined by the supplier of each of the lymphokines. Hybridoma lines 11Bll (anti-Ib4) (22) and S4B6 (anti-IL,2) (2) were kindly provided by Dr. W. Paul (National Institutes of Health, Bethesda, MD) and Dr. T. Mosmann (DNAX), respectively. The 145-2Cll (anti-CD3-e) hybtidoma cell line was kindly provided by Dr. J. Bluestone (University of Chicago) (23) .
T Cell Clones. The OVA-reactive T.0 clones and the T.1 clone PGLIO were derived from DBA/2 and BALB/c mice using methods described previously (5) . The conalbumin-specific T.2 clone D10.G4.1 was obtained from Dr. C. Janeway (Yale University, New Haven, CT), and has been described (24) . Cloned cells were maintained by weekly restimuhtion with irradiated (2,000 tad) syngeneic spleen cells, antigen, and riD2. For experiments, ceils were harvested 7-10 d after passage, and purified by centrifugation over a Ficoll-Hypaque gradient (25) .
Isolation of Splenic B Cells. Adherent cells were removed by incubating 10 s spleen cells in tissue culture dishes (model 3003; Falcon Labware, Oxnard, CA) in complete medium containing 5% FCS at 37~ for 1.5 h. Nonadherent cells were recovered by gentle rinsing, and transferred to a glass tube (Vacutainer 6430; Becton Dickinson & Co., Rutherford, NJ) which had previously been autoclaved with 0.2 mg carbonyl iron (9) . After incubation at 37~ for 1.5 h, the contents of the tube were gently resuspended and iron was retained in the bottom of the tube with a magnet while the cell suspension was removed with a pipette. Residual iron particles were removed by slow centrifugation (600 rpm for 30 s). T cells and residual macrophages were removed by incubation with the AT83A (anti-Thyl) and M1/70 (anti-MAC-I) mAb along with Low-Tox guinea pig complement (Accurate Chemical & Scientific Corp., Westbury, NY) for 1 h at 37~ The final cell suspension was purified by Ficoll-Hypaque centrifugation. The resulting cell population typically consisted of >95% B cells as assessed by flow cytometry using anti-Ig and anti-B220 Abs (data not shown).
Induction of Anergy. For treatment with anti-CD3 mAb, culture wells of 24 well plates (Linbro 76-033-055; Flow Laboratories, McLean, VA) were coated overnight at 37~ with 0.5 ml of goat anti-hamster antiserum (Cooper Biomedical, Malveru, PA) at a concentration of 40/~g/ml in Dulbecco's PBS (DPBS) (26) . They were then washed twice with 1 ml DPBS and received 0.5 ml of a 1:20 dilution of 145-2Cll hybridoma superuatant in DPBS and incubated at 37aC for 2 h. After again washing twice, each well received 106 cloned T cells in a final volume of 1 ml. For other anergy treatments, cells were stimulated with Ionomycin (1 /~M) or purified B cells (6 x 106) and OVA (800/~g/ml). Cells were collected 24-72 h later, purified by Ficoll-Hypaque centtifugation, and assayed for functional and biochemical characteristics. Cell yield varied from 40 to 90% of the original number of cells cultured. For lyraphokine assays, supernatants were collected after 21-24 h at 37~ centrifuged to remove cells, and stored at 4~ until assayed.
T Cell Cytolytic Assays. Cloned cells were mixed at the indicated effector/target cell ratios with SlCr-labeled, OVA-pulsed LK35.2 cells, as described (27) . Chromium release was assessed at 5h.
Lymphokine Assays. IFN-7 concentrations were determined using an ELISA develol~l by Dr. R. Schreiber (Washington Universit),, St. Louis, MO) (28) , who also generously provided the necessary reagents. Activity in culture supernatants was compared to that in a standard (kindly provided by the National Institute of Allergy and Infectious Diseases, No. Gg02-901-533). ID5 was measured with a specific ELISA, using reagents generously provided by Dr. R. Coffman (DNAX). I1,2 and Ib4 concentrations were determined using a subclone of the CTLb2 indicator line that proliferated well in response to either lymphokine. Serial dilutious of test supernatants were compared with dilutions of known concentrations of recombinant standards in the presence of anti-Ib2 mAb, anti-IL-4 mAb, both mAbs, or neither. Cell viability was assessed using the colorimetric MTT assay (29) . 
Analysis of Cells by Flow

Measurement of lntracellular Free Calcium. Cells were incubated
in complete medium containing 5% FCS with 8 pJC[ Indo-1 acetoxymethylester for 1 h at 37~ at a final concentration of 2 x 107 cells/ml. They were then washed with DMEM and incubated for an additional 30-60 min at 37~ in fresh complete medium. CeUs were again washed, resuspended at 106 cells/m1 in complete medium, and maintained in this medium until analysis. For analysis, cells were resuspended in 2 ml of a buffer consisting of 150 mM NaCI, 5 raM KC1, 1.2 mM MgCh, 10 mM glucose, 10 mM MOPS, 0.3% BSA, and 1 mM CaCI2. Fluorescence measurements were made on samples maintained at 37~ using a spectrofluorometer (model LB-S5; Perkin-Elmer Corp., Norwalk, CT). Indo-1 fluorescence was excited at 330 nm (10-urn bandwidth), and emission was measured at 400 nm (10 nm bandwidth). Con A was used at a final concentration of 10 ~tg/ml. Cells were lysed with dlgitonln to determine Fro, and Fm was determined by addition of 4 mM EGTA and sufficient Tris base to raise the pH above 8. 
Results
Anti-CD3 mAl~ Ionomycin, or B Cells Plus Antigen Induce a Subsequent Defect in IL-2 but not IL-4 Production by T,O Clones.
Unresponsiveness with respect to IL-2 production can be induced in T.1 clones with several different stimuli that activate the TCK-mediated signaling pathway in the absence of fully competent APCs (16). However, IL-4 production by T.2 dories is little affected by similar treatments (18, 19 , and Gajewski, T., unpublished observations). Since these cell types appear to possess several differences in their TCRassociated signaling mechanisms (13) , it was conceivable that the selective effect on IL-2 but not IL-4 production resulted from an anergizing signal being generated in T.1 but not T.2 cells rather than the lack of a response of the IL-4 gene to the anergizing stimulus. To address this question, we examined the effect of anergizing stimuli on subsequent responsiveness of T.0 clones, which produce both IL-2 and IL-4. The cell lines used were believed to be donal based on limiting dilution frequency anal)sis, homogeneous morphology, and the fact that they were recloned early after derivation by micromanipulation (data not shown). Five T.0 clones isolated from BALB/c mice were stimulated for 24 h with immobilized anti-CD3 mAb, purified by Ficoll-Hypaque centrifugation, then restimulated with anti-CD3 mAb for assessment of lymphokine production. Control cells were either harvested directly from passage cultures or incubated overnight in culture medium alone, with similar results. As shown in Fig. 1 , or syngeneic splenic B cells (6 x 10 ~) and OVA (800/zg/ml) (C); control cells for each were maintained in rIL-2 (2 U/ml) for the same time period. Cells were then purified by Ficoll-Hypaque centrifugation, restimulated with immobilized anti-CD3 mAb, and supernatants were collected and assessed for ID2 and IIr4 concentrafions. Results are presented as percent control values, and are representative of two to four e~periments. duction phase. Similar results were obtained when cells were cultured with anti-CD3 mAb for 72 h or 7 d (data not shown), suggesting that the lack of effect on IL-4 production was not a result of slower kinetics of inhibition of this lymphokine, and also that the inhibition of IL-2 production was not related to a transient unresponsive state occurring during early activation events. In addition, when treated cells were removed from the Ab, rested in culture medium for 7 d, and restimuhted with anti-CD3 mAb, they continued to produce dramatically reduced levels of IL-2 compared to control cells (data not shown), arguing that the induced phenotype was relatively long-lived, as has been demonstrated for T.1 clones (14) . Induction of unresponsiveness to T.1 cells with respect to IL-2 production appears to be calcium dependent and can be mimicked with the calcium ionophore, Ionomycin (31) . It was conceivable that the T.0 clones generated a sufficient increase in [Ca 2 + ]i to inhibit subsequent production of IL-2 but not IL-4. Therefore, we examined the effect of Ionomycin pretreatment on subsequent lymphokine production by the T.0 clones. As shown in Fig. 1 B, Ionomycin also impaired the ability of these cells to produce IL-2 but not IL-4 when restimulated via the TCR complex. In fact, Ionomycin typically enhanced subsequent IL-4 production, exaggerating further the new lymphokine profile produced by the treated cells.
We also determined if T.0 cells could be anergized with a more physiologic stimulus. It has been shown that anergy can be induced in T.1 clones with specific peptide presented by chemically treated spleen cells, purified dams II MHC molecules in planar membranes, or purified resting B cells (16, 32, 33) . We chose purified B cells as APCs for our system because they might represent one cell type that can induce anerg'y in vivo, and because they effectively stimulate proliferation of T.2 but not T.1 clones in vitro (10) . As depicted in Fig. 1 C for three T.0 clones, exposure to antigen and purified B cells also induced subsequent decrease in IL-2 but not IL-4 production. These results suggest that TO) calls that encounter B cells presenting the rdevant antigenic peptide during an immune response in vivo might subsequently produce IL-4 but substantially less IL-2, effectively transforming the T cell phenotype to a T.2-like response.
Effect of Anergizing Stimuli on Production of Additional Lymphokines by T.O Clones. Studies of anergy with T.1 clones
have suggested that, whereas IL-2 production and proliferation are dramatically reduced after induction of the anergic state, production of other lymphokines, such as IL-3 and IFN-'y, is marginally affected (16) . Therefore, we next examined the effect of anergizing stimuli on the production of additional lymphokines by T.0 clones. For these studies, a new panel of clones was derived from DBA/2 mice, and screened for the production of IFN-'y in addition to IL-2 and IL-4. As shown in Fig. 2 , two subtypes of TH0 clones were obtained, one which produced IFN-3, and the other which did not. In addition, it was noted that the frequency of IFN-3,-producing T.0 clones, as well as the concentration of IFN-'y produced by individual clones, was increased if the cells were derived in the presence of exogenous IFN-3' (Fig.  2) . T.0 clones that produced IL-2 and IL-4 were designated T.0-A cells, and those that produced IL-2, IL-4, and IFN-'y were designated T.0-B cells, a nomenclature suggested previously (34). All T.0 dones examined also produced IL-3, IL-5, and TNF activity (data not shown).
T.0-A and T.0-B clones were treated for 72 h with anti-CD3 mAb, then assessed for the ability to produce multiple lymphokines upon restimuhtion with anti-CD3 mAb. As shown in Fig. 3 for two TO clones of each subtype, production of IL-2 was completely inhibited by prior exposure to anti-CD3 mAb. In contrast, the ability to produce IL-4, IL-5, and IPN~ was little affected by the anergizing stimulus. Sinai- larly, IL-3 production was only modestly affected by prior exposure to anti-CD3 mAb (data not shown). The T.0-A clones that did not produce IFN-~/in the resting state did not acquire the ability to produce IFN-'y after pretreatment with anti-CD3 mAb. Similar results were obtained for several additional T.0 clones of each subtype (data not shown). These results suggest that the anergizing signal exerts a potent inhibitory effect that is relatively specific for production of IL-2. Effects on secretion of additional lymphokines are modest and vary between individual clones. In addition, since the ability to produce both IL-4 and IL-5 persists, they suggest that a functional T.2-1ike phenotype could be retained after exposure of T.0-A cells to anergizing stimuli. 35) . Interestingly, as depicted in Fig. 4 using two T.0 clones of each subtype, when T.0 ceUs were treated with immobilized anti-CD3 mAb, they subsequently displayed markedly decreased lyric activity for OVApulsed B lymphoma cells compared to untreated cells. This effect was nearly complete for the T~0-A clones, which generally lysed less well to begin with (Fig. 4, A and B) .
T.O Cells Anergized with Anti-CD3 raAb Have Diminished
Similar results were obtained with several additional T.0 clones derived from BALB/c and DBA/2 mice (data not shown). These observations are in stark contrast to those obtained with T,1 clones, which when anergized with anti-CD3 mAb, retained their cytolytic capability (36, and data not shown). These results suggest that exposure of T.0 dones to anergizing stimuli can alter multiple functions in those cells, not only their lymphokine profile. Moreover, they suggest that stimulation of T.0 cells via the TCR complex might generate a signal that does not occur after stimulation of T.1 cells, one which results in disengagement of subsequent cytolytic capability.
It has been suggested that T.1 cells as a group proliferate better than T.2 cells (37) . Hence, the effect of pretreatment of T.0 clones with anti-CD3 mAb on subsequent antigenspecific proliferation of those cells also was examined. Proliferation of anergized T.0 cells in response to syngeneic spleen cells and OVA was partially reduced, ranging from 10 to 90%, compared to control cells (data not shown). These results also are consistent with inhibition of IL-2 production after exposure to anti-CD3 mAb and predominant utilization of IL-4 rather than IL-2 as an autocrine growth factor.
Surface Phenotype of Anergized T~O Cells, It was conceiv-
able that treatment of the T cell clones with immobilized anti-CD3 mAb might alter significantly the expression of surface molecules necessary for activation. Inasmuch as restimulation of the cells was performed with immobilized anti-CD3 mAb, expression of the TCR-cdj8 heterodimer, CD3-e, and CD4 was examined. As shown in Fig, 5 , anergized T.0 cells did not express reduced levels of any of these markers, the mean fluorescence of each being comparable to that found in resting ceils. The histograms corresponding to the treated ceUs are slightly more heterogeneous, probably reflecting the relative size increase seen after induction of anergy with anti-CD3 mAb.
The morphologic phenotype of anergic T.0 ceils also was examined. The TH1 and Tx2 clones we have studied are morphologically dissimilar in that TH2 ceils are typically larger and more rounded compared to T.1 cells, which are smaller and more dub shaped. This is illustrated in Fig. 6 with photographs of a T.1 done PGL10 (Fig. 4 A) and the prototypic T.2 clone D10.G4.1 (Fig. 4 B) , purified by FicoilHypaque centrifugation after 7 d in passage culture. The T.0 clones resembled TH1 cells, being relatively small and dub shaped, although they typically appeared slightly larger than T.1 ceils (Fig. 4 C) . Interestingly, after anergy with anti-CD3 mAb, the T.0 cells became larger and rounder, appearing more like a Tx2 clone (Fig. 4 D) . Similar results were observed after induction of anergy of T.1 cells (data not shown). After 7 d, they still retained this larger size, as if they had arrested in the middle of bhst phase (data not shown). These observations suggest that T.1 and T.2 cells might possess different cytoskeletal arrangements, and imply that a reorganization of the cytoskeleton might occur after induction of the anergic state.
Altered Signal Transduction in Anergized T.O Cells, We have reported previously that, in contrast to T~I clones, TH2 clones manifest little or no detectable devation of [Ca z + ]i or inositol phosphates after stimulation via the TCR complex, suggesting utilization of a distinct signal transduction mechanism (13) . In light of these results, it was of interest to examine the change in [CaZ+]i in T.0 ceils, which share char- For comparison, change in [Ca 2+ ]i was also examined in resting splenic CD4 + T cells isolated by positive sorting with anti-CD4 mAb (Fig. 7) . Resting CD4 + spleen cells, which produce predominantly IL-2 after stimulation via the TCR. complex (5), generated a brisk calcium flux in response to Con A, similar to that observed with T.1 clones. Similar results were obtained using cells enriched by negative depletion with a cocktail of anti-CD8, anti-B220, anti-Ig, and anti-MAC-1 mAbs (data not shown), suggesting that the anti-CD4 mAb used for sorting had no effect on signaling. If T.2 cells indeed differentiate from the IL-2-producing population of naive CD4 + T cells, this result suggests that as they acquire the ability to produce IL-4 and pass through a TO intermediate stage, they gradually lose the capability of signaling via the calcium pathway.
It was of interest to explore the effect of anergizing stimuli on signal transduction in T,0 ceils and determine if there were alterations that correlated with the observed changes in function. This was addressed by examining changes in [Ca2+]i in treated cells. The typical vigorous calcium flux observed with the representative T.1 done PGL10 is depicted in Fig. 8 A, and the minimal calcium response observed with the T.2 done D10 is represented in Fig. 8 B. Interestingly, the intermediate calcium response seen with Figure 7 . Changes in [C#+]i in response to TCR ligation of HTL subsets. Four HTL clones representing each of the indicated subsets were collected from passage cultures, purified by Hcoll-Hypaque centtifugation, and loaded with the calcium indicator dye Indo-1. CD4 + spleen cells were isolated by positive sorting with FITC-conjugated anti-CD4 mAb and also loaded with Indo-1. They were then stimulated with Con A (10 V.g/ml), and changes in fluorescence were monitored using a spectrofluorometer. Calciura concentrations were determined as described in Materials and Methods. Results are expressed as percent increase over baseline values. a representative T.0-B clone (Fig. 8 C) was nearly completely abrogated after induction of anergy with anti-CD3 mAb (Fig. 8 D) . Thus, anergic T.0 cells have a blunted elevation of [Ca2+]i upon restimulation, similar to that observed with T.2 clones.
This response was examined more carefully with several additional T.0-A and T.0-B clones. When actual [Ca2+]i concentrations were calculated, several conclusions emerged. First, the IFN-3~-producing T.0-B calls had a lower basal [Ca 2+ It compared to the T.0-A dones (Fig. 9) . This result is reminiscent of observations made with T.1 and T,2 clones, the former having relatively lower [Ca2+]i in the resting state compared to the latter (13) . Second, after primary activation via the TCP, complex, the [Ca2+]i for all clones approached approximately the same plateau, around 200 nM in these experiments. Third, after anergy with anti-CD3 mAb, the basal [Ca2+]i was markedly devated at '~,200 riM, and did not significantly increase after subsequent restimulation via the TCP, complex (Fig. 9 ). This signal phenotype is similar to that observed previously with T.2 clones (13). Collectively, these results suggest that as HTL develop down the T.2 pathway, they acquire an increased basal intracellular caldum concentration, which is not increased much further when those ceils encounter TCK stimulation.
Discussion
Clonal anergy was first described in a T.1 done after stimulation with chemically treated spleen calls and specific antigenic peptide (14) . Subsequently, it was found that anergy could be induced by additional stimuli, including antigenic peptide presented either by purified class II MHC proteins in planar lipid membranes or by small resting B cells, anti-TCR mAbs, the T cell mitogen Con A, and the calcium ionophore, Ionomycin (15, 16, (31) (32) (33) . All these stimuli lack the ability to provide a costimulator signal delivered by particular APCs that prevents induction of anergy. This cofactor may be identical to the cofactor necessary for optimal proliferation of T.1 cells (10) . In fact, it has been suggested that proliferation per se is the event necessary to avoid induction of anergy (38) . The fact that Ionomycin alone is sufficient for the generation of the unresponsive state suggests that calcium elevation in the absence of a signal delivered by the costimulator molecule is the essential biochemical step during the induction phase. In contrast to T.1 cells, anergy of T.2 cells with respect to IL-4 production has been difficult to demonstrate (18) . It was conceivable that this difference was secondary to different signals being generated after engagement of the TCR complex in the two cell types. In our present study, immobilized anti-CD3 mAb, Ionomycin, or purified B cells and antigen, all were able to induce anergy with respect to IL-2 but not IL-4 production in T.0 clones. The fact that anergizing stimuli led to inhibition of expression of one lymphokine gene but not another in the same cells, suggests that the anergy effect is specific for IL-2 and not IL-4 gene expression. It is likely that IL-4 production by T.2 clones cannot be anergized because expression of the IL-4 gene is insensitive to the effects of anergizing stimuli. In fact, Ionomycin alone actually stimulates production of IL-4 by T.2 clones (13) . Other lymphokines that are only partially inhibited after exposure to anergizing stimuli, such as IFN-7 and IL-3 (16), probably rely on multiple signaling pathways for their expression, only some of which are inhibited in the anergic state.
Recently, other investigators (34) have reported similar induction of anergy by anti-CD3 mAb with respect to IL-2 but not IL-4 production in T.0 clones. In that study, it is argued that the cells do not acquire a T.2 phenotype because the anergizing stimulus also induces reduced ability to proliferate in response to IL-4. However, T.2 cells generally proliferate less vigorously in response to antigenic stimulation than T.1 cells. In addition, we have observed that the majority of our clones previously characterized as T.2 cells do not proliferate well in response to exogenous IL-4. although their modest autocrine proliferation is inhibited by anti-IL-4 mAb (Gajewski, T., unpublished observations). Therefore, the reduced ability to proliferate might not be uncharacteristic of T.2 clones, and is not inconsistent with the possibility that induction of anergy in T.0 ceils may lead to a TH2-1ike phenotype.
Antigen-specific cytolytic activity also was inhibited in anergic T.0 cells, demonstrating that more than one functional trait can be significantly affected. Interestingly, cytolytic activity was not affected after anergy of several T.1 clones (36, and Lancki, D. W., and T. Gajewski, unpublished observations), nor was it found to be inhibited in anergic IL-2-producing CD8 + CTL clones (40) . These results suggest that the TCR-mediated signals that are coupled to the cytolytic machinery in T.1 and T.0 cells may be differentially influenced by anergizing stimuli. Alternatively, T.1 and T.0 cells might employ distinct mechanisms of cytolysis (27) , only one of which is affected in the anergic state. The fact that multiple T.I-like functions were reduced after induction of anergy of T.0 cells supports the notion that a T.2-1ike phenotype is emerging under those conditions. Whether or not anergy of T.0 cells renders them better able to provide help for B cell proliferation and Ab production remains to be examined. In addition, the pattern of tyrosine phosphorylated substrates seen after TCR ligation of anergized T.0 clones also is altered, more resembling that of T.2 cells (Gajewski, T., and D. Qian, unpublished observations), implying that multiple aspects of TCR-mediated signal transduction are modified in anergized T.0 clones. If T.2 cells indeed arise when T.0 cells are exposed to anergizing stimuli, these results also suggest the possibility that the signaling characteristics of T.2 cells may be a secondary event, the result of repeated engagement with APCs lacking costimulator activity, induction of anergy with respect to IL-2 production, and downregulation of the Tal-type signaling pathway. Thus, the lack of a calcium flux may correlate with the T.2 phenotype, essentially being a marker for their history of being activated in the absence of a costimulator signal, but might not actually mediate the T.2 phenotype. Several APC-derived costimulator molecules and their associated receptors have been identified that may mediate costimulation and prevent induction of anergy in T.1 cells. CTLA4 (41) and CD28 (42) are two costimulator receptors expressed on T lymphocytes, both of which can bind to the molecule B7 expressed on activated B lymphocytes and other cell types (43) . Heat stable antigen also has been suggested to serve as a receptor for a costimulator molecule (44) . It will be of interest to examine the expression and activity of these molecules with respect to the various HTL subsets, and to determine ff simultaneous ligation of any of these molecules and the TCR complex can prevent the transition of T.0 cells into a T.2 phenotype.
Several cytokines have been shown to facilitate differentiation of newly activated HTLs into mature T.1 or T.2 cells. IFN-7 appears to favor emergence of a T.1 phenotype (5), perhaps by increasing the frequency of T.0 cells that produce IFN-3, (see Fig. 2 ). IL-12 has recently been shown also to promote generation of a T.1 phenotype, by a mechanism that may depend upon IFN-3' activity (45) . Conversely, the presence of IL-10 and IL-4 during HTL activation appears to result in preferential emergence of a T.2 phenotype (46). It is unclear whether these cytokines act directly on T lymphocytes, or indirectly via APCs, to exert all of their diffa~mtiation-inducing effects. It is conceivable that expression of costimulator molecules on the APC population, or responsiveness of the T ceils to costimulation, is modulated by these cytokines, thus determining ff the developing T cell is exposed to stimulation via the TCR alone or simultaneously with a costimulatory signal. These possibilities remain to be examined.
A proposed model for the ontogeny of T.1 and T.2 cells with the potential influence of anergizing stimuli is summarized in Fig. 10 . Naive CD4 + T cells, when first activated via the TCR. complex, respond with a brisk elevation in [Ca2+]i and produce predominantly IL-2. This primary activation event induces a differentiation process that allows the cell to express additional lymphokine genes, perhaps alI lymphokine genes that HTL are capable of transcribing, thus giving rise to the T.0 phenotype. The presence of IFN-~' during this period may determine if the T.0 cell itself acquires the ability to produce IFN-% Associated with an expanded lymphokine program is cytolytic activity, and moderately altered signal transduction, manifested by a reduced calcium flux. It is possible that the T.0 cell expresses quantitatively hss of the T.1 signaling enzymes, or that acquisition of T.2 traits inhibits some aspects of T~I signaling. When cells at the T.0 stage are stimulated in the absence of a costimulator molecule, the T.1 program might be inhibited, giving rise to a I".2 phenotype. These calls then have reduced cytolytic capability and lack a substantial calcium flux. In addition, the basal levd of [Ca2 § rises as the developing cell becomes more T.2-1ike. Such a situation might occur when resting B cells are the predominant APCs participating in the ongoing immune response, as these calls can induce anergy of T.1 clones (32, 33) and inhibit the T.1 characteristics of T.0 clones (see Fig. 1 ). Mature T.2 calls, therefore, retain the ability to proliferate in the absence of costimulator signals, and B cells can serve as optimal APCs for this cell subset (10) . Conversely, although not examined in this study, cells of the T.1 phenotype may arise when the T.0 ceils are stimulated in the presence of a costimulator signal, perhaps under the additional influence of the cytokines IL-12 and IL-% However, it is interesting that both naive HTL and mature T.1 cells exhibit a vigorous calcium flux, whereas T.0 cells have one of intermediate magnitude. This result suggests the possibility that T.1 cells may arise directly from naive CD4 + HTL precursors, and that the T~0 call is only an intermediate in the differentiation pathway of T.2 ceils. These aspects of the ontogenetic model have yet to be examined. The cell culture model for inducing clonal anergy probably reflects a mechanism by which peripheral tolerance of T lymphocytes can be achieved in vivo (17, 47) . Application of these concepts might provide a means by which to deliberately induce specific T cell unresponsiveness during situations of undesirable T ceil activation, such as autoimmune diseases or ailogeneic transplant. However, our results suggest that attempts at inducing specific anergy in vivo, after an immune response has already been initiated and a T.0 phenotype has been generated, might resu/t not in complete anergy, but rather a T.2-centered immune response. In fact, it has been demonstrated that neonatal exposure to alloantigens results, not in complete tolerance, but in the generation of cells that produce IL-4 (48) . Additional in vivo models will need to be explored to further test these hypotheses.
